Adapted Mindfulness Training for Diabetic Patients With Impaired Hypoglycemia Awareness
2026年5月8日 更新者:Mengyao Han、Yangzhou University
Impact of Adapted Mindfulness Training Integrating Interoception on Diabetic Patients With Impaired Awareness of Hypoglycemia: A Randomized Controlled Trial
The purpose of this randomized controlled trial is to evaluate the effectiveness of an 8-week interoception-integrated adapted mindfulness training program for patients with type 1 or type 2 diabetes who experience impaired awareness of hypoglycemia (IAH).
The study aims to determine whether this mindfulness intervention, which includes techniques such as body scanning and mindful eating, can help patients better recognize early physiological signals of low blood sugar compared to routine care.
Researchers will measure changes in participants' interoceptive awareness and the severity of their IAH over a 3-month follow-up period.
The ultimate goal is to provide a practical psychological approach to improve symptom perception and reduce the risk of severe hypoglycemic events in diabetic patients.
調査の概要
状態
まだ募集していません
詳細な説明
Diabetic patients are prone to hypoglycemia during insulin therapy, and repeated episodes can lead to impaired awareness of hypoglycemia (IAH), significantly increasing the incidence of severe hypoglycemia and adverse health outcomes.
Recent studies indicate that altered interoceptive awareness is closely associated with an increased risk of IAH, and mindfulness interventions can effectively enhance an individual's interoceptive awareness.
This study aims to explore the effects of an interoception-integrated adapted mindfulness training program on interoceptive awareness and impaired awareness of hypoglycemia in diabetic patients.
This study is a two-arm, parallel-group randomized controlled trial.
It plans to recruit 100 type 1 or type 2 diabetic patients with IAH who meet the eligibility criteria (e.g., Gold score ≥ 4 and Clarke score ≥ 4) from two community health centers in Yangzhou.
Participants will be randomly assigned in a 1:1 ratio to either the intervention group (n=50) or the control group (n=50).
The control group will receive routine treatment, examinations, nursing care, and health education.
On this basis, the intervention group will receive an 8-week interoception-integrated adapted mindfulness training program, conducted once a week (1-1.5 hours per session).
Based on Mindfulness-Based Stress Reduction (MBSR), the program utilizes core techniques such as body scanning, mindful eating, and mindful walking to reinforce patients' perception and awareness of early physiological signals of hypoglycemia, supplemented by daily home practices.
Primary outcomes are the patients' interoceptive awareness (assessed by the MAIA-2 scale) and the severity of impaired awareness of hypoglycemia (evaluated by the Clarke and Gold questionnaires).
Secondary outcomes include mindfulness levels (FFMQ) and negative cognitive processing bias (NCPBQ).
Data collection time points are set at pre-intervention (T0), immediately post-intervention (T1), 1 month post-intervention (T2), and 3 months post-intervention (T3).
Statistical analyses will employ descriptive statistics, univariate analysis, and Generalized Estimating Equations (GEE) to evaluate the intervention effects.
This study is expected to provide a practical psychological intervention to improve symptom perception in diabetic patients with IAH, thereby reducing the incidence of severe hypoglycemia and improving clinical outcomes.
研究の種類
介入
入学 (推定)
100
段階
- 適用できない
参加基準
研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
いいえ
説明
Inclusion Criteria:
- Diagnosed with type 1 or type 2 diabetes mellitus according to the latest American Diabetes Association (ADA) Standards of Care in Diabetes;
- Receiving insulin therapy for ≥ 1 year;
- Age between 18 and 80 years (inclusive);
- Duration of diabetes ≥ 5 years;
- Gold score ≥ 4 and Clarke score ≥ 4;
- Voluntary participation and provision of signed informed consent.
Exclusion Criteria:
- Prior experience with mindfulness interventions;
- Diagnosed with cognitive impairment, psychiatric disorders, or other severe physical comorbidities;
- Current use of psychotropic medications;
- Pregnant or lactating women, or women of childbearing potential not using effective contraception.
研究計画
このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:支持療法
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:ダブル
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Intervention Group
Participants receive an 8-week interoception-integrated adapted mindfulness training program, in addition to routine treatment, examinations, nursing care, and health education.
|
An 8-week adapted mindfulness program, based on Mindfulness-Based Stress Reduction (MBSR), is delivered to patients with Impaired Awareness of Hypoglycemia (IAH) by a multidisciplinary team.
It involves weekly 1-1.5 hour face-to-face group sessions (8-10 participants) and daily home practices supervised via a WeChat group.
Tailored to IAH, the curriculum integrates core skills (mindful meditation, yoga, breathing, and walking) with IAH-specific elements.
By training self-awareness, attentional control, and emotional regulation, it aims to enhance interoceptive awareness.
This strengthens hypoglycemia-related perceptual behaviors, helping patients acquire self-regulation skills, attend to physical sensations of hypoglycemia, perceive nocturnal hypoglycemia, and identify fear of hypoglycemia.
|
|
アクティブコンパレータ:Control Group
Participants receive routine treatment, examinations, nursing care, and health education only, without the mindfulness training during the 8-week study period.
|
The control group receives routine medical care, examinations, nursing, and health education.
While they undergo the same follow-up schedule as the intervention group, no mindfulness practice guidance is provided during the study period.
Upon the conclusion of the study, mindfulness-related materials will be distributed to these participants.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
時間枠 |
|---|---|
|
Clark Score
時間枠:Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
|
Gold Score
時間枠:Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
|
Multidimensional Assessment of Interoceptive Awareness Version 2
時間枠:Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
二次結果の測定
結果測定 |
時間枠 |
|---|---|
|
Five Facet Mindfulness
時間枠:Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
|
Negative Cognitive Processing Bias Questionnaire
時間枠:Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
協力者と研究者
ここでは、この調査に関係する人々や組織を見つけることができます。
スポンサー
研究記録日
これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。
主要日程の研究
研究開始 (推定)
2026年6月1日
一次修了 (推定)
2027年6月1日
研究の完了 (推定)
2027年6月1日
試験登録日
最初に提出
2026年5月8日
QC基準を満たした最初の提出物
2026年5月8日
最初の投稿 (実際)
2026年5月14日
学習記録の更新
投稿された最後の更新 (実際)
2026年5月14日
QC基準を満たした最後の更新が送信されました
2026年5月8日
最終確認日
2026年5月1日
詳しくは
本研究に関する用語
その他の研究ID番号
- YZUHL20250040
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
いいえ
米国FDA規制機器製品の研究
いいえ
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。